Meeting
2017 ASCO Annual Meeting
Two-year clinical outcomes of de-intensified chemoradiotherapy for low-risk HPV-associated oropharyngeal squamous cell carcinoma.
Authors
Bhishamjit S. Chera
The University of North Carolina at Chapel Hill, Chapel Hill, NC
Bhishamjit S. Chera , Robert J Amdur , Joel E. Tepper , Bahjat F. Qaqish , David N. Hayes , Jared Weiss , Juneko E. Grilley-Olson , Adam M Zanation , Trevor Hackman , Jose Zevallos , Samip Patel , Nathan Christopher Sheets , Mark Christian Weissler , William M. Mendenhall
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT01530997
Citation
J Clin Oncol 35, 2017 (suppl; abstr 6044)
DOI
10.1200/JCO.2017.35.15_suppl.6044
Abstract #
6044
Poster Bd #
32
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Mature results of the LCCC1413 phase II trial of de-intensified chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma.
First Author: Bhishamjit S. Chera
Poster
2013 ASCO Annual Meeting
Phase II study of de-intensification of radiation and chemotherapy for low-risk HPV-related oropharyngeal squamous cell carcinoma.
First Author: Bhishamjit S. Chera
Poster
2020 ASCO Virtual Scientific Program
Pathological response rates and quality of life outcomes of neoadjuvant cabazitaxel and cisplatin chemotherapy for muscle-invasive transitional cell carcinoma of the urinary bladder.
First Author: Amarnath Challapalli
Poster
2019 Genitourinary Cancers Symposium
Comparing clinical outcomes between patients with urothelial carcinoma who treated neoadjuvant chemotherapy by gemcitabine-cisplatin and dose-dense MVAC.
First Author: Yongjune Lee